Article info
Letter
Bosentan therapy for patients with severe Raynaud’s phenomenon in systemic sclerosis
- Dr M E Hettema, Division of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands; m.e.hettema{at}int.umcg.nl
Citation
Bosentan therapy for patients with severe Raynaud’s phenomenon in systemic sclerosis
Publication history
- Accepted March 31, 2007
- First published September 19, 2007.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2007 BMJ Publishing Group Ltd and European League Against Rheumatism